Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004466807 | SCV004964428 | uncertain significance | not specified | 2023-12-07 | criteria provided, single submitter | clinical testing | The c.695T>G (p.F232C) alteration is located in exon 4 (coding exon 3) of the TDRD5 gene. This alteration results from a T to G substitution at nucleotide position 695, causing the phenylalanine (F) at amino acid position 232 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |